WEBULL
WebtradeDownload

Li-S Energy Leads The Pack Of 3 ASX Penny Stocks

Simply Wall St · 2d ago

As the Australian market gears up for a new week, investors are cautiously optimistic, with major Wall Street indexes closing in the green and local futures suggesting a mixed start. In this climate of fluctuating bond yields and geopolitical tensions, selecting stocks with potential is crucial. While the term "penny stocks" may seem outdated, these affordable shares in smaller or newer companies can still offer significant growth opportunities when supported by strong financials.

Here we highlight a subset of our preferred stocks from the screener.

Li-S Energy (ASX:LIS)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Li-S Energy Limited focuses on developing and commercializing lithium sulphur and metal batteries in Australia, with a market capitalization of A$85.15 million.

Operations: Li-S Energy Limited has not reported any revenue segments.

Market Cap: A$85.15M

Li-S Energy Limited, with a market cap of A$85.15 million, remains pre-revenue but is making strides in the lithium-sulfur battery sector. Recent strategic alliances highlight its involvement in defense and aerospace, notably with successful test flights of drones powered by its batteries and deliveries to the US Army for evaluation. The company has secured critical international transport approvals, enhancing its operational capabilities. Despite reporting a net loss of A$4.86 million for the year ending June 2026, Li-S Energy's experienced management team and board are navigating regulatory achievements that could support future growth opportunities in high-profile sectors.

ASX:LIS Debt to Equity History and Analysis as at Oct 2026
ASX:LIS Debt to Equity History and Analysis as at Oct 2026

Prairie Lithium (ASX:PL9)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Prairie Lithium Limited is a mineral exploration company operating in the United States, Canada, and Australia with a market cap of A$34.68 million.

Operations: Currently, there are no reported revenue segments for this mineral exploration company.

Market Cap: A$34.68M

Prairie Lithium Limited, with a market cap of A$34.68 million, is pre-revenue and remains unprofitable, reporting a net loss of A$3.46 million for the year ending June 2026. Despite this, the company has no debt and its short-term assets significantly exceed liabilities (A$6.1M vs A$487.4K). The management team and board are experienced, with average tenures of three and five years respectively. While its share price has been highly volatile recently, there hasn't been significant shareholder dilution over the past year. Prairie Lithium's strategic presence in key markets was highlighted at the Canada Investment Summit 2026.

ASX:PL9 Financial Position Analysis as at Oct 2026
ASX:PL9 Financial Position Analysis as at Oct 2026

Resonance Health (ASX:RHT)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Resonance Health Limited is a healthcare technology and services company that designs, develops, manufactures, and commercializes software-as-medical devices across various regions including the Asia Pacific, North America, Europe, the Middle East, and Africa with a market cap of A$38.17 million.

Operations: The company generates revenue primarily from its Resonance Clinical segment with A$7.54 million, followed by its SaMD (including Research & Development) with A$7.04 million, and Trialswest contributing A$4.15 million.

Market Cap: A$38.17M

Resonance Health Limited, with a market cap of A$38.17 million, has transitioned to profitability, reporting A$1.51 million in net income for the fiscal year ending June 2026. The company's revenue grew to A$15.75 million from A$11.07 million the previous year, driven by its Resonance Clinical and SaMD segments. Its financial stability is underscored by short-term assets exceeding liabilities and more cash than total debt, while interest payments are well-covered by EBIT (5.7x). Despite a low Return on Equity at 13.6%, earnings quality remains high with no significant shareholder dilution recently observed.

ASX:RHT Revenue & Expenses Breakdown as at Oct 2026
ASX:RHT Revenue & Expenses Breakdown as at Oct 2026

Summing It All Up

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.